Welcome to Waterloo.ai
Artificial Intelligence (AI) will change our lives – transforming how we work, how we travel, how we treat disease, how we communicate, and how we learn.
The Waterloo Artificial Intelligence Institute (Waterloo.ai) has a vital role to play. Researchers at the University of Waterloo are developing intelligent systems that can detect cancer and heart disease, understand language and emotion, and navigate roadways and factory floors better than ever before. But we’re just getting started. Our constant focus on key technologies and on the foundational breakthroughs to make them a reality will accelerate AI innovation that benefits everyone, everywhere.
Waterloo’s track record of partnership with industry will allow us to deliver effective AI innovation for hundreds and thousands of businesses across Canada – a truly inclusive AI revolution. Canadian start-ups, Small-to-medium enterprises (SMEs) and corporations will be able to pioneer new technologies in medical care, assistive devices, environmental monitoring, adaptive robotics, and autonomous driving.
Building on this expertise and experience, Waterloo is producing end-to-end AI solutions of immediate benefit to all Canadians. In years to come, we expect this research investment to yield profound dividends for the economic prosperity, wellbeing and quality of life of people all around the world.
- Jan. 8, 2019
University of Waterloo has hit the headlines again! The university was recently was named as one of the Americas' 5 most innovative universities for AI and robotics!
1. Massachusetts Institute of Technology (MIT), USA
2. Carnegie Mellon University, USA
3. University of Southern California (USC), USA
4. University of Waterloo, Canada
5. University of São Paulo, Brazil
- Dec. 12, 2018
The use of artificial intelligence (AI) is making it possible to discover new drugs faster, cheaper and more efficiently.
Waterloo chemists have introduced AI to interpret the results acquired by the differential mobility spectrometry (DMS) technique to predict drug properties. This could reduce in principle the time between concept and coming to market of new drugs by years and decrease production costs by $100s of million.
- Dec. 6, 2018
Alexander Wong, a Canada Research Chair in the field of Artificial Intelligence and an associate professor in the Department of Systems Deign Engineering, is interviewed in The O'Reilly Data Show on his research on designing a human-in-the-loop platform for building deep neural networks with efficient network architectures.